Cond line) p-value Monotherapy EverolimusET n:16 primarily based therapy n:22 0.410 ten (34) 13 (56) Group C
Cond line) p-value Monotherapy EverolimusET n:16 based therapy n:22 0.410 ten (34) 13 (56) Group C (CDKi in 3rd line) p-value Monotherapy EverolimusET n:17 based therapy n:38 0.126 7 (34)…